What the Clinical Research Shows Phase 1 and Phase 2 clinical trial data for retatrutide including data from the TRIUMPH program has demonstrated significant reductions in body weight and improvements in glycemic markers across diverse research populations
For example, obese patients given 500 mg thrice daily for 12 weeks achieved significant improvements: 5 lbs weight loss and a 23% reduction in triglycerides with a 12% drop in total cholesterol
Comprehensive medication reconciliation allows clinicians to identify potential interactions, provide individualized guidance, and monitor for adverse effects, especially in patients with diabetes, thyroid disorders, or other medical conditions
85 Unlike ischemic stroke, which comes from a blocked vessel, intracerebral hemorrhage involves mechanical damage from the expanding blood clot, followed by secondary injury from hemoglobin toxicity, oxidative stress, blood-brain barrier disruption, and inflammation
She can recommend the most suitable options tailored to your needs
